ARCHIVES

Regional Groups: Why 15 Were Not Among Those Funded; Cancer Regional Studies Review Committee Chartered

This article is from The Cancer Letter archive.

Vol. 08 No. 27 | July 2, 1982

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

DePinho Explains Tenure Decision,Professors Dispute Key Details

May 30, 2014

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

June 2, 2000

Missouri, Michigan Program As For Comprehensive Review

September 23, 1977

Alan Rabson Named Acting NCI Director

October 5, 2001

In Brief: GAO Says Congress Should Re-Examine Delaney Clause, Consider Making It More Flexible

January 8, 1982